Dysesthesia an unpleasant sensation on the skin, often described as crawling, tingling, or burning without obvious cause showed up in about 1 in 5 participants on the retatrutide 12 mg arm in TRIUMPH-4
Data availability The nuclear magnetic resonance and mass spectrometry data are provided in the Supplementary Information
Despite promising preclinical studies, a 12-week clinical trial using an iteration of this initial dual-incretin agonist failed to demonstrate superiority relative to a GLP-1R monoagonist 15 , raising questions about multi-receptor strategies in humans
doi: 10.1016/j.nutres.2015.03.004
1,6,7 Options include SGLT-2 inhibitors, which also have cardiorenal protective benefits, or sulfonylureas
If you start on these medicines, and then you lose 5, 10, or 15% of your body weight, very often, you will have an improvement in ovulation, As for the phenomenon of Ozempic pregnancy while taking contraceptives, doctors are still looking for an explanation